A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person

Sponsor

State University of New York - Upstate Medical University (Other)

Overall Status

Terminated

CT.gov ID

NCT00629434

Collaborator

(none)

Enrollment

Location

Arms

Duration (Months)

0.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study compares group diabetes education in-person versus via telemedicine

Condition or Disease	Intervention/Treatment	Phase
Diabetes Mellitus	Other: diabetes education via telemedicine Other: diabetes education in-person	N/A

Detailed Description

Diabetes education is important in the treatment of the person with diabetes. A diabetes self-management education program not only educates the patient and his/her family to the basics of diabetes care but also integrates diabetes care into daily life while providing coping skills to adjust to this chronic illness. Unfortunately, comprehensive diabetes care is not available to all persons with diabetes. One obstacle to the provision of comprehensive diabetes care is the unavailability of a diabetes treatment center. many people with diabetes live too far or do not have the transportation to be able to attend education programs that met national standards. We have shown that telemedicine is an effective means to provide comprehensive 1:1 individualized diabetes education to persons with diabetes. We now propose to test the hypothesis that diabetes groups education classes can be provided effectively through telemedicine technology to individuals living in rural areas. Patients with diabetes will received diabetes education via teleconferencing from our Joslin Diabetes center. The participants will be assessed before and after diabetes education via telemedicine using measures of glycemia (A1c) and assessments of patient satisfaction, emotional well being, and behavioral change and compared to results from participants attending our diabetes education classes in-person.

Study Design

Study Type:

Interventional

Actual Enrollment :

68 participants

Allocation:

Non-Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person

Study Start Date :

Jun 1, 2001

Actual Primary Completion Date :

Jun 1, 2008

Actual Study Completion Date :

Aug 1, 2008

Arms and Interventions

Arm	Intervention/Treatment
Experimental: 1 This arm will receive diabetes education via telemedicine	Other: diabetes education via telemedicine This arm will receive diabetes group education via telemedicine
Active Comparator: 2 diabetes education in-person	Other: diabetes education in-person In this arm the group of patients with diabetes will receive diabetes education in-person

Arm

Intervention/Treatment

Experimental: 1

This arm will receive diabetes education via telemedicine

Other: diabetes education via telemedicine

This arm will receive diabetes group education via telemedicine

Active Comparator: 2

diabetes education in-person

Other: diabetes education in-person

In this arm the group of patients with diabetes will receive diabetes education in-person

Outcome Measures

Primary Outcome Measures

A1c [baseline, 3 mo post intervention, 6 mo post intervention]

Secondary Outcome Measures

PAID scale [baseline, 3 and 6 months post intervention]
Diabetes Treatment Satisfaction Questionnaire [Baseline, 3 and 6 months post intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 85 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Type 1 or type 2 diabetes mellitus
age > 18 years

Exclusion Criteria:

Profound vision loss
Severe hearing impairment

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Joslin Diabetes Center Affiliate at SUNY Upstate Medical University	Syracuse	New York	United States	13214

Sponsors and Collaborators

State University of New York - Upstate Medical University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

, ,

ClinicalTrials.gov Identifier:

NCT00629434

Other Study ID Numbers:

UMU IRB # 4510F
UMU IRB # 4510F

First Posted:

Mar 6, 2008

Last Update Posted:

Oct 6, 2021

Last Verified:

Oct 1, 2021

Keywords provided by , ,

Diabetes Education

Telemedicine

Additional relevant MeSH terms:

Diabetes Mellitus

Study Results

No Results Posted as of Oct 6, 2021